Mauna Kea Technologies and Tasly Pharmaceutical Announce the Incorporation of Joint Venture in China Read more
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company Read more
Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders Read more
AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN LIPOPROTEIN(A) LEVELS Read more
Hexvix, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial Read more
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary Read more
European Commission grants first approval worldwide of Beyfortus (nirsevimab) for prevention of RSV disease in infants Read more
NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced Parkinson’s Disease Read more
BeiGene Receives European Commission Approval for BRUKINSA (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma Read more
REITHERA EXPANDS LARGE-SCALE VIRAL VECTOR PRODUCTION CAPABILITIES WITH OPENING OF NEW MANUFACTURING FACILITY Read more